Post COVID-19 conditions in an Australian pediatric cohort, 3 months following a Delta outbreak

Philip N Britton1,2,3, Rebecca Burrell4,5, Emily Chapman6

  • 1The Children's Hospital at Westmead Clinical School, Sydney Medical School, the University of Sydney, Westmead, NSW, Australia. philip.britton@health.nsw.gov.au.

Pediatric Research
|August 30, 2024
PubMed

Insights

Pediatric Long COVID is infrequent in Australian children, with most recovering within 12 weeks. However, a minority experience persistent symptoms, highlighting the need for ongoing attention to post-COVID conditions.

Area of Science:

  • Pediatric infectious diseases
  • Public health surveillance
  • Clinical immunology

Background:

  • Pediatric long COVID remains poorly understood, with limited Australian data.
  • The 2021 Delta variant outbreak provided a specific cohort for study.

Purpose of the Study:

  • To assess symptoms and functional impairment 12 weeks post-infection in Australian children and adolescents.
  • To evaluate the impact of the SARS-CoV-2 Delta variant on pediatric recovery.

Main Methods:

  • Online survey distributed to parents/carers of 11,864 PCR-confirmed SARS-CoV-2 cases.
  • Assessment of symptoms and functional impairment at 12 weeks post-infection.
  • Clinical review for patients reporting non-recovery.

Main Results:

  • 17.6% of invited parents responded to the survey.
  • 11.7% reported persistent symptoms or functional impairment.
  • Of those reviewed, 37.3% had Post COVID Conditions (PCC), and 12.4% met Long COVID criteria.

Conclusions:

  • Self-reported non-recovery in children is infrequent but warrants attention.
  • Long COVID is a subset of non-recovery cases, affecting a minority of pediatric patients.
  • Risk factors for pediatric post-COVID conditions include age over 11 and pre-existing comorbidities.
Abstract